Loading the section
Closing prices for 09 October 2026
Next earnings report: 30 October 2026, before market open · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
AstraZeneca PLC trades on NYSE under the ticker AZN. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks AZN has traded between 153.41 $ and 212.71 $. As of 09 October 2026 the price stood 9.76 % of the way from the 52-week low to the high.
Over one year AZN shares fell 6.77 %; over six months they fell 21.97 %. Volatility over 90 days is 31.35 %. Dividends are not included: this is price change only, as of 09 October 2026.
AstraZeneca PLC reported revenue of 58.7B $ and net income of 10.2B $ for the latest fiscal year. Net margin is 17.42 %. Revenue changed by +8.63 % year over year. Earnings per share are 6.54 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 159.45 | 160.06 | 158.56 | 159.20 | 2M |
| 08 October 2026 | 159.80 | 160.05 | 156.72 | 158.78 | 3M |
| 07 October 2026 | 159.12 | 161.29 | 158.53 | 160.12 | 2M |
| 06 October 2026 | 159.80 | 159.96 |
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
AstraZeneca PLC (AZN) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 58.7bn $, net income was 10.2bn $. Incorporated in GB.
This summary is compiled automatically from SEC filings and exchange data.
Address:1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
AZN has a return on equity of 21.00 %, above the sector median of −41.68 %. Return on assets is 8.97 %, above the sector median of −32.11 %. Operating margin is 23.40 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 156.26 |
| 158.61 |
| 2M |
| 05 October 2026 | 156.76 | 157.20 | 154.81 | 156.53 | 2M |
| 02 October 2026 | 158.46 | 158.80 | 156.41 | 156.90 | 3M |
| 01 October 2026 | 160.77 | 161.33 | 157.54 | 157.70 | 3M |
| 30 September 2026 | 164.47 | 164.48 | 161.46 | 161.47 | 2M |
| 29 September 2026 | 165.09 | 166.47 | 163.24 | 164.21 | 3M |
| 28 September 2026 | 165.69 | 167.52 | 165.39 | 166.15 | 2M |
| 25 September 2026 | 166.16 | 166.81 | 164.60 | 166.58 | 2M |
| 24 September 2026 | 162.91 | 166.25 | 162.91 | 164.56 | 3M |
| 23 September 2026 | 166.58 | 167.59 | 163.33 | 163.33 | 2M |
| 22 September 2026 | 167.84 | 169.35 | 166.74 | 168.37 | 2M |
| 21 September 2026 | 168.45 | 169.00 | 167.11 | 168.10 | 3M |
| 18 September 2026 | 167.15 | 167.83 | 165.54 | 166.08 | 3M |
| 17 September 2026 | 164.59 | 166.29 | 164.30 | 166.14 | 4M |
| 16 September 2026 | 164.21 | 165.42 | 162.02 | 162.89 | 4M |
| 15 September 2026 | 161.42 | 163.90 | 160.71 | 161.85 | 3M |
| 14 September 2026 | 164.08 | 164.55 | 162.14 | 163.78 | 3M |